Okedi (Risperidone vial)

Okedi from Europe is now available.

Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.

According to the European Medicines Agency, brand name Okedi originating from Europe is manufactured at the following site(s):Laboratorios Farmacéuticos Rovi, S.A. Julián Camarillo, 35 28037 Madrid Spain

Information about Okedi (Risperidone Vial)

Okedi is a brand of risperidone, an atypical antipsychotic medication available in injectable form (vial). It is used primarily for the management of schizophrenia, bipolar disorder, and other psychiatric conditions. The injectable formulation allows for long-acting delivery, making it useful for patients who may have difficulty adhering to oral medication regimens.

Product Highlights

• Treatment of symptoms related to schizophrenia in adults and adolescents.
• Acute treatment of manic or mixed episodes associated with bipolar I disorder.
• Often used in patients with acute psychotic episodes or severe agitation, especially when oral medications are not an option.
• Can be used in conjunction with other medications for certain psychiatric disorders.

Key Ingredient

• Risperidone

Key Benefits

• Long-acting injectable formulation helps ensure consistent medication delivery.
• Helps reduce symptoms of psychosis, agitation, and mood swings in conditions like schizophrenia and bipolar disorder.
• The injectable form provides sustained release, lowering the risk of relapse due to missed doses.
• Compared to older antipsychotics, risperidone tends to have a more favorable side effect profile, though still carries some risks.

Direction of Use

• Administered by a healthcare professional as an intramuscular (IM) injection.
• Injection is typically given in the gluteal or deltoid muscle, and the exact dose and frequency depend on the patient's condition and doctor’s recommendations.
• Dosing intervals can range from weekly to monthly depending on the formulation (e.g., risperidone long-acting injectable).

Safety Concerns

• Risk of movement disorders such as tremors, rigidity, or tardive dyskinesia, though these are less common with atypical antipsychotics.
• Can lead to weight gain, increased blood sugar, and cholesterol levels, potentially contributing to diabetes or cardiovascular issues.
• May cause sedation or dizziness, especially when starting treatment.
• A drop in blood pressure upon standing, leading to dizziness or fainting.
• Rare, but caution is needed in patients with heart conditions or those on other medications that prolong the QT interval.

Avoid Okedi (Risperidone Vial) If

• You are allergic to risperidone or any other ingredients in the formulation.
• You have a history of severe heart conditions, such as arrhythmias or QT prolongation.
• You have severe liver or kidney dysfunction without proper dose adjustments.
• You are taking other medications that increase the risk of serotonin syndrome or neuroleptic malignant syndrome (a rare but serious condition).